483
Hemarus LLCFDA 483 - Hemarus LLC - November 04, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Hemarus Plasma in Lauderhill, FL, a plasma center, was cited for two observations during an FDA inspection. The inspection revealed inadequate privacy for donor screenings due to uncovered and non-acoustically protected booths, and a failure to thoroughly investigate donor adverse reactions. Several adverse event reports were found missing crucial follow-up and review information.
Open in Dashboard
ID · c54fbafa-ffa0-497a-b14b-3817b0e650a7